Sandoz Pharmaceuticals AG - Estalis 50/250, transdermale Pflaster |
| 54704 | | 02 | | Estalis 50/250 | | transdermale Pflaster | | G03FA01 | | Norethisterone and Estrogen | | 17.08.1999 | | |
|
Composition |
estradiolum 0.496 mg ut estradiolum hemihydricum 0.512 mg, norethisteroni acetas 4.8 mg, silicone adhesive, acrylic adhesive, povidonum K 30, acidum oleicum, dipropylenglycolum, Trägermaterial: ad praeparationem pro 16 cm², cum liberatione 50 µg et 250 µg/24 h. |
Packungsbestandteile |
| Transdermal patch | | | Active Agent | Dose |
---|
Estradiol | 0.496 mg | Norethisterone Acetate | 4.8 mg |
| BAG: Active Agent | Dose |
---|
Estradiol | 0.496 mg | Norethisterone Acetate | 4.8 mg |
| | Inactive agents | Dose | additional_information |
---|
Acidum Oleicum | | | Acrylic Adhesive | | | Ad Praeparationem | 16 cm | Trägermaterial | Cum Liberatione | 50µg et 250 µg / 24h | | Dipropylenglycol | | | Povidonum K | 30 | | Silicone Adhesive | | |
| |
|
|